rs9622979
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002608.4(PDGFB):c.161-80C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0681 in 978,628 control chromosomes in the GnomAD database, including 3,400 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 1088 hom., cov: 32)
Exomes 𝑓: 0.062 ( 2312 hom. )
Consequence
PDGFB
NM_002608.4 intron
NM_002608.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.66
Publications
8 publications found
Genes affected
PDGFB (HGNC:8800): (platelet derived growth factor subunit B) This gene encodes a member of the protein family comprised of both platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF). The encoded preproprotein is proteolytically processed to generate platelet-derived growth factor subunit B, which can homodimerize, or alternatively, heterodimerize with the related platelet-derived growth factor subunit A. These proteins bind and activate PDGF receptor tyrosine kinases, which play a role in a wide range of developmental processes. Mutations in this gene are associated with meningioma. Reciprocal translocations between chromosomes 22 and 17, at sites where this gene and that for collagen type 1, alpha 1 are located, are associated with dermatofibrosarcoma protuberans, a rare skin tumor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
PDGFB Gene-Disease associations (from GenCC):
- basal ganglia calcification, idiopathic, 5Inheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- bilateral striopallidodentate calcinosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial meningiomaInheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 22-39233604-G-A is Benign according to our data. Variant chr22-39233604-G-A is described in ClinVar as Benign. ClinVar VariationId is 1262479.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.187 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PDGFB | NM_002608.4 | c.161-80C>T | intron_variant | Intron 2 of 6 | ENST00000331163.11 | NP_002599.1 | ||
| PDGFB | NM_033016.3 | c.116-80C>T | intron_variant | Intron 2 of 6 | NP_148937.1 | |||
| PDGFB | XM_047441393.1 | c.68-80C>T | intron_variant | Intron 2 of 6 | XP_047297349.1 | |||
| PDGFB | XM_047441394.1 | c.68-80C>T | intron_variant | Intron 2 of 6 | XP_047297350.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PDGFB | ENST00000331163.11 | c.161-80C>T | intron_variant | Intron 2 of 6 | 1 | NM_002608.4 | ENSP00000330382.6 | |||
| PDGFB | ENST00000381551.8 | c.116-80C>T | intron_variant | Intron 2 of 6 | 5 | ENSP00000370963.4 | ||||
| PDGFB | ENST00000455790.5 | c.68-80C>T | intron_variant | Intron 2 of 4 | 4 | ENSP00000402306.1 | ||||
| PDGFB | ENST00000440375.1 | c.68-80C>T | intron_variant | Intron 2 of 4 | 4 | ENSP00000405780.1 |
Frequencies
GnomAD3 genomes AF: 0.102 AC: 15549AN: 152000Hom.: 1076 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
15549
AN:
152000
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0617 AC: 50998AN: 826510Hom.: 2312 AF XY: 0.0648 AC XY: 27562AN XY: 425290 show subpopulations
GnomAD4 exome
AF:
AC:
50998
AN:
826510
Hom.:
AF XY:
AC XY:
27562
AN XY:
425290
show subpopulations
African (AFR)
AF:
AC:
3406
AN:
17696
American (AMR)
AF:
AC:
2952
AN:
23744
Ashkenazi Jewish (ASJ)
AF:
AC:
1741
AN:
17318
East Asian (EAS)
AF:
AC:
1413
AN:
31760
South Asian (SAS)
AF:
AC:
8619
AN:
57162
European-Finnish (FIN)
AF:
AC:
1922
AN:
44300
Middle Eastern (MID)
AF:
AC:
416
AN:
3878
European-Non Finnish (NFE)
AF:
AC:
27706
AN:
592182
Other (OTH)
AF:
AC:
2823
AN:
38470
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2328
4656
6983
9311
11639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.103 AC: 15607AN: 152118Hom.: 1088 Cov.: 32 AF XY: 0.103 AC XY: 7667AN XY: 74380 show subpopulations
GnomAD4 genome
AF:
AC:
15607
AN:
152118
Hom.:
Cov.:
32
AF XY:
AC XY:
7667
AN XY:
74380
show subpopulations
African (AFR)
AF:
AC:
7910
AN:
41460
American (AMR)
AF:
AC:
1861
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
334
AN:
3472
East Asian (EAS)
AF:
AC:
412
AN:
5150
South Asian (SAS)
AF:
AC:
750
AN:
4822
European-Finnish (FIN)
AF:
AC:
461
AN:
10606
Middle Eastern (MID)
AF:
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3569
AN:
68002
Other (OTH)
AF:
AC:
228
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
704
1408
2113
2817
3521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
438
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.